Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease

Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease

Dry eye disease (DED) or keratoconjunctivitis sicca is a chronic multifactorial disorder of the ocular surface caused by tear film dysfunction. Symptoms include dryness, irritation, discomfort and visual disturbance, and standard treatment includes the use of lubricants and topical steroids. Seconda...

Full description

Bibliographic Details
Main Authors: Sangeeta Kumari, Madhuri Dandamudi, Sweta Rani, Elke Behaeghel, Gautam Behl, David Kent, Niall J. O’Reilly, Orla O’Donovan, Peter McLoughlin, Laurence Fitzhenry
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Pharmaceutics
Subjects:
dry eye disease
keratoconjunctivitis sicca
dexamethasone
corticosteroid
biomarker
nanostructured lipid carrier
Online Access:https://www.mdpi.com/1999-4923/13/6/905

Internet

https://www.mdpi.com/1999-4923/13/6/905

Similar Items